Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR
FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) ("Hydreight" or the "Company"), a leader in U.S. nationwide digital healthcare solutions, is pleased to announce that, further to the news release of the Company dated January 15, 2026, it has closed its previously announced "bought deal" private placement with Canaccord Genuity Corp. (the "Lead Underwriter") as lead underwriter and sole bookrunner, and Beacon Securities Limited (together with the Lead Underwriter, the "Underwriters"). The Company issued 3,705,000 units of the Company (each, a "Unit") at a price of $4.05 per Unit for aggregate gross proceeds of $15,005,250 (the "Offering"). The Offering was conducted pursuant to an underwriting agreement dated January 27, 2026, between the Company and the Underwriters.
Shane Madden, the Chief Executive Officer of the Company, commented:
“This financing was oversubscribed within hours of announcement, reflecting strong conviction in Hydreight’s execution and the durability of our model. Q4 marked a clear inflection point for the business — expanding proven pharmacy product lines and launching high-demand products continued to drive real, scalable growth across all three verticals, and that momentum has carried decisively into 2026 with increasing visibility.
The addition of multiple new high quality institutional investors at this stage meaningfully and strategically bolsters our share register while providing further validation of our platform and is an important step as we scale. With this additional capital, we are positioned to further accelerate customer growth by expanding our technology and platform offerings, increasing production capacity, accelerating new product rollouts, and strengthening the infrastructure required to support growing demand across our nationwide network. We believe these investments position the Company for another year of outsized, exponential growth.”
The terms of the Offering consisted of the sale of up to 2,470,000 Units, subject to an option of the Underwriters to increase the number of offered Units by up to an additional 1,235,000 Units (the "Underwriters' Option"). The Underwriters' Option was exercised in full for a total of 1,235,000 additional Units. The Units were issued on a private placement basis (i) in reliance on the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106") as modified by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "Listed Issuer Financing Exemption") in each of the Provinces and Territories of Canada, (ii) in the United States and to, or for the account or benefit of, U.S. persons pursuant to an exemption from the registration requirements of the United States Securities Act of 1933 (the “U.S. Securities Act”), as amended, and (iii) in such other jurisdictions other than Canada and the United States pursuant to relevant prospectus or registration exemptions in accordance with applicable laws, provided that no prospectus filing or comparable obligation, ongoing reporting or continuous disclosure requirement or requisite regulatory or governmental approval arose in such jurisdictions.
Each Unit consists of one common share in the capital of the Company (each, a "Unit Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant") of the Company. The Warrants were issued pursuant to a warrant indenture dated January 27, 2026, between the Company and Odyssey Trust Company as warrant agent and each Warrant entitles the holder thereof to acquire one common share of the Company (each, a "Warrant Share") at a price of $5.27 per Warrant Share for a period of 24 months from the closing date of the Offering.
As consideration for acting as underwriters, the Underwriters received (i) a cash commission of $900,315, and (ii) 222,300 non-transferable broker warrants (the "Broker Warrants"), exercisable for a period of 24 months following the closing date of the Offering to acquire, in aggregate, that number of common shares in the capital of the Company (the "Broker Warrant Shares") at an exercise price equal to $4.05 per Broker Warrant Share.
The Units issued under the Listed Issuer Financing Exemption, including the Unit Shares and any Warrant Shares, are not subject to a hold period pursuant to applicable Canadian securities laws.
The Company intends to use the net proceeds raised from the Offering to support sales growth, for creating and expanding existing pharmacy production lines and for working capital and general corporate purposes as further described in the Company's offering document under the Listed Issuer Financing Exemption dated January 15, 2026.
The securities described herein have not been, and will not be, registered under the U.S. Securities Act, or any securities laws of any state of the United States, and accordingly, may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of the securities referenced in this press release, in any jurisdiction in which such offer, solicitation or sale would be unlawful. "United States" and "U.S. persons" are as defined in Regulation S under the U.S. Securities Act.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Hydreight Technologies Inc.
Hydreight Technologies Inc. is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains statements that constitute “forward-looking information” or “forward-looking statements” (together “forward-looking statements”) within the meaning of applicable Canadian and United States securities laws. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified by the use of terminology such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words, or statements that certain actions, events or results "may", "could", "would", "might", "will be taken", "occur" or "be achieved". Forward-looking statements, including but not limited to the intended use of the net proceeds raised from the Offering, are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation, with respect to the Offering and the issuance of the Units, including conditions of financial markets, economic conditions including any governmental regulations with respect thereto including tariffs, protective governmental regulations, consumer responses to such actions and other related effects, management's discretion with respect to the use of proceeds and the use of the available funds following completion of the Offering, including the timing and cost of planned corporate projects and developments and the use of funds in connection therewith, and the other risk factors described in our securities filings available at www.sedarplus.ca. Forward-looking statements or forward-looking information relate to future events and future performance and include statements regarding the expectations and beliefs of management based on information currently available to the Company.
Although the Company believes that the assumptions and factors used in preparing these forward- looking statements are reasonable based upon the information currently available to management as of the date hereof, actual results and developments may differ materially from those contemplated by these statements and no assurance can be given that such events will occur in the disclosed times frames or at all. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are therefore cautioned not to place undue reliance on forward-looking statements and forward-looking information. Any forward-looking statement speaks only as of the date of this news release and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, changing circumstances, or otherwise.
For further information, please contact:
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
Email: ir@hydreight.com
Phone: (480) 790 6886
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
